{"date":"2026-06-30","count":40,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6734-2026-06-30-2010-15xi27q","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"20:10:43","subject":"公告本公司115年5月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-06-30 20:10，「公告本公司115年5月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-06-30-1853-15zzt4o","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"18:53:13","subject":"本公司董事會決議取得合躍生活廣場事業(股)公司普通股","clause":"第20款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-06-30 18:53，「本公司董事會決議取得合躍生活廣場事業(股)公司普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-30-1849-1iiw2er","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"18:49:48","subject":"代子公司明基健康生活股份有限公司公告董事會決議出售所持合躍生活廣場事業股份有限公司普通股。","clause":"第20款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-30 18:49，「代子公司明基健康生活股份有限公司公告董事會決議出售所持合躍生活廣場事業股份有限公司普通股。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-06-30-1817-16y0bl7","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"18:17:05","subject":"公告本公司審計委員會委員辭任","clause":"第6款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-06-30 18:17，「公告本公司審計委員會委員辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-06-30-1816-qrsqda","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"18:16:28","subject":"公告本公司獨立董事辭任","clause":"第6款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-06-30 18:16，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-06-30-1811-7wwxp","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"18:11:43","subject":"公告本公司董事會決議委任第六屆薪資報酬委員會委員及推選召集人","clause":"第6款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-06-30 18:11，「公告本公司董事會決議委任第六屆薪資報酬委員會委員及推選召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-06-30-1811-17ndua8","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"18:11:07","subject":"公告本公司董事會選任董事長（續任）","clause":"第6款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-06-30 18:11，「公告本公司董事會選任董事長（續任）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-06-30-1739-vmx9s","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"17:39:55","subject":"新藥OBP-301在美執行的食道癌第一期臨床試驗論文發表","clause":"第53款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-06-30 17:39，「新藥OBP-301在美執行的食道癌第一期臨床試驗論文發表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-06-30-1737-1efbul1","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-06-30","time":"17:37:17","subject":"代子公司青松長照社團法人公告向關係人取得使用權資產","clause":"第20款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-06-30 17:37，「代子公司青松長照社團法人公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-06-30-1736-1efbul1","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-06-30","time":"17:36:51","subject":"代子公司青松長照社團法人公告向關係人取得使用權資產","clause":"第20款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-06-30 17:36，「代子公司青松長照社團法人公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-06-30-1736-8gnt5y","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-06-30","time":"17:36:25","subject":"代子公司青松長照社團法人公告向關係人處分使用權資產(提前終止租賃契約)","clause":"第20款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-06-30 17:36，「代子公司青松長照社團法人公告向關係人處分使用權資產(提前終止租賃契約)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-06-30-1735-61lzrd","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"17:35:07","subject":"公告本公司除權基準日相關事宜","clause":"第14款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-06-30 17:35，「公告本公司除權基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-06-30-1735-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"17:35:04","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-06-30 17:35，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-06-30-1718-1lxab2n","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"17:18:43","subject":"公告本公司受邀參加群益證券與IR Trust舉辦之「再生醫療與消費醫療產業」論壇。","clause":"第30款","fact_date":"2026-07-01","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-06-30 17:18，「公告本公司受邀參加群益證券與IR Trust舉辦之「再生醫療與消費醫療產業」論壇。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-06-30-1708-13sk2v0","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"17:08:33","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-06-30 17:08，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-06-30-1707-qrsqda","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"17:07:37","subject":"公告本公司獨立董事辭任","clause":"第6款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-06-30 17:07，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-06-30-1705-15oidu9","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"17:05:00","subject":"公告本公司公司治理主管異動案","clause":"第11款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-06-30 17:05，「公告本公司公司治理主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-06-30-1644-1jb8ii5","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"16:44:34","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-06-30 16:44，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-06-30-1627-17i351v","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"16:27:03","subject":"公告本公司董事長決議訂定114年度現金股利除息基準日","clause":"第31款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-06-30 16:27，「公告本公司董事長決議訂定114年度現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-06-30-1622-i1vdhe","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-06-30","time":"16:22:08","subject":"代子公司公告：(BVI) Chlitina Group Limited等子公司公告決議配發現金股息之相關事宜","clause":"第14款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-06-30 16:22，「代子公司公告：(BVI) Chlitina Group Limited等子公司公告決議配發現金股息之相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-06-30-1619-fr5elf","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-06-30","time":"16:19:51","subject":"公告本公司收到美國 FDA Type C 會議正式紀錄，支持 HCB101 於二線胃癌／胃食管結合部癌之後續開發方向。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-06-30 16:19，「公告本公司收到美國 FDA Type C 會議正式紀錄，支持 HCB101 於二線胃癌／胃食管結合部癌之後續開發方向。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-06-30-1617-1s3jlig","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"16:17:50","subject":"公告本公司董事長訂定除息基準日暨現金股利發放日","clause":"第31款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-06-30 16:17，「公告本公司董事長訂定除息基準日暨現金股利發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-06-30-1616-1bkm0mx","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"16:16:43","subject":"公告本公司代理發言人異動","clause":"第8款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-06-30 16:16，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-06-30-1615-1vhu1xi","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"16:15:47","subject":"公告本公司發言人異動","clause":"第8款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-06-30 16:15，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-06-30-1612-tyqdgp","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"16:12:49","subject":"公告本公司115年股東會決議解除董事競業禁止之限制案","clause":"第22款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-06-30 16:12，「公告本公司115年股東會決議解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-06-30-1607-1jb8ii5","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"16:07:47","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-06-30 16:07，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-06-30-1606-1fktm3p","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"16:06:35","subject":"公告本公司英文名稱變更","clause":"第44款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-06-30 16:06，「公告本公司英文名稱變更」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-06-30-1604-1g69yl9","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"16:04:41","subject":"公告本公司115年股東常會決議通過解除董事競業禁止之限制案","clause":"第22款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-06-30 16:04，「公告本公司115年股東常會決議通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-06-30-1601-1bs0239","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"16:01:34","subject":"公告本公司董事選任事宜","clause":"第6款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-06-30 16:01，「公告本公司董事選任事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-06-30-1557-jflio5","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"15:57:31","subject":"公告本公司115年股東會重要決議事項","clause":"第15款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-06-30 15:57，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-06-30-1556-5cj96r","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"15:56:48","subject":"本公司115年股東會重要決議事項","clause":"第15款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-06-30 15:56，「本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-06-30-1548-mr1837","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"15:48:34","subject":"公告本公司副總經理暨研發主管異動","clause":"第11款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-06-30 15:48，「公告本公司副總經理暨研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-06-30-1545-1jb8ii5","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"15:45:30","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-06-30 15:45，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-06-30-1522-1wh8jtg","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-06-30","time":"15:22:23","subject":"代子公司欣安健康事業(股)公司公告股東會決議分配股利","clause":"第14款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-06-30 15:22，「代子公司欣安健康事業(股)公司公告股東會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-06-30-1503-5rax5d","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"15:03:56","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-06-30 15:03，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-06-30-1503-1g69yl9","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"15:03:36","subject":"公告本公司115年股東常會決議通過解除董事競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-06-30 15:03，「公告本公司115年股東常會決議通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-06-30-1503-1jb8ii5","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"15:03:11","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-06-30 15:03，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-06-30-1337-15dzpbv","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"13:37:22","subject":"公告本公司董事會通過財務長、財務主管、代理發言人異動","clause":"第11款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-06-30 13:37，「公告本公司董事會通過財務長、財務主管、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-06-30-0652-1s8ds3k","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-06-30","time":"06:52:16","subject":"公告本公司決議申請調整115年度現金增資發行股數案。","clause":"第44款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-06-30 06:52，「公告本公司決議申請調整115年度現金增資發行股數案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-06-30-0601-10zdto7","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-30","time":"06:01:30","subject":"代子公司共信醫藥科技股份有限公司公告向歐洲專利辦公室提出之專利申請案號：EP 21873130.5 已獲核准通知","clause":"第53款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-06-30 06:01，「代子公司共信醫藥科技股份有限公司公告向歐洲專利辦公室提出之專利申請案號：EP 21873130.5 已獲核准通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}